Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03118843 |
|---|---|
| Brief Title: | Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study |
| First Submitted : | April 13, 2017 |
| First Submitted that Met QC Criteria : | April 17, 2017 |
| First Posted : | April 18, 2017 |
| Results First Submitted : | March 8, 2019 |
| Results First Submitted that Met QC Criteria : | March 8, 2019 |
| Results First Posted : | April 3, 2019 |
| Last Update Submitted that Met QC Criteria : | March 8, 2019 |
| Last Update Posted : | April 3, 2019 |